Why Monopar Therapeutics (MNPR) is a Strong Candidate for Trend Investing

When it comes to short-term investing, many traders say that "the trend is your friend." This principle underscores a common strategy that can lead to profitable opportunities. However, confirming the durability of a trend to ensure ongoing profitability is often more challenging than it appears.

Trends can reverse unexpectedly, leaving investors facing short-term losses. For a successful trade, it is essential to verify certain factors, like robust fundamentals and positive earnings revision estimates, that can sustain a stock's momentum.

A tool that assists in this evaluation is a "Recent Price Strength" screening strategy, designed for short-term trading. This screen identifies stocks with strong fundamentals that are trending upward. It specifically highlights companies trading near the upper end of their 52-week high-low range, an indicator of bullish sentiment.

Overview of Monopar Therapeutics Inc.

Among the stocks meeting this criterion is Monopar Therapeutics (MNPR). Here’s why MNPR stands out as a compelling choice for trend-focused investors.

First, MNPR has shown remarkable price growth, rising an impressive 842.7% over the last 12 weeks. This significant increase indicates that investors see potential value in this stock.

However, to ensure that this growth is not just a fleeting moment, it’s crucial to look at shorter time frames too. Notably, MNPR has maintained a positive trajectory, increasing in price by 54% in the past four weeks. This consistency is a strong indicator that the stock's uptrend remains intact.

Currently, MNPR is trading at about 83% of its 52-week high-low range, suggesting that it could be due for a potential breakout. This statistic adds to the stock's attractiveness as it indicates strong price action.

On the fundamental side, MNPR boasts a Zacks Rank of #2 (Buy), placing it within the top 20% of over 4,000 stocks ranked based on trends in earnings estimate revisions and EPS surprises. These elements often have significant effects on a stock's price movements in the near term.

The Zacks Rank rating system assesses stocks on their earnings estimates and categorizes them from #1 (Strong Buy) to #5 (Strong Sell). Historically, Zacks Rank #1 stocks have averaged annual returns of +25% since 1988. Thus, MNPR's strong rating reflects its positive outlook.

Additionally, the Average Broker Recommendation for MNPR is #1 (Strong Buy), indicating strong optimism among analysts regarding the stock's near-term performance.

Given these factors, the upward trend for MNPR appears likely to continue for the foreseeable future.

Aside from MNPR, many other stocks also pass through the “Recent Price Strength” screen. Investors might want to explore these options as well, searching for new stocks that align with these successful criteria.

While MNPR is a strong candidate, it’s essential not to limit yourself to a single screening strategy. Depending on individual investment preferences, over 45 Zacks Premium Screens are available to help find stocks poised to outperform the market.

Ultimately, successful stock picking hinges on a strategy that has shown profitable outcomes in the past, something that can be verified using tools like the Zacks Research Wizard. This tool allows users to backtest various strategies and access a selection of successful stock-picking methodologies.

For those interested in exploring these opportunities, consider signing up for a free trial of the Research Wizard.

Investing, Stocks, Trend